Skip to main content

Table 1 HIV rapid tests and chemiluminescent immunoassays used at study sites*

From: HIV Surveillance in a Large, Community-Based Study: Results from the Pilot Study of Project Accept (HIV Prevention Trials Network 043)

  Thailand Tanzania Zimbabwe South Africa Vulindlela South Africa Soweto
Assay #1 Determine HIV 1/2a Determine HIV 1/2a Determine HIV 1/2a Determine HIV 1/2a Determine HIV 1/2a
Assay #2 Bioline HIV1/2a,b SD Bioline HIV 1/2 v3a Uni-Gold HIVa SD Bioline HIV 1/2 v3a SD Bioline HIV 1/2 v3a or Uni-Gold HIVa
Assay #3 (tie-breaker) Clearview* HIV 1/2 STAT-PAKc Uni-Gold HIVa OraQuick HIV-1/2 Rapid Antibody Testc ARCHITECT HIV Ag/Ab Combo CMIAc ARCHITECT HIV Ag/Ab Combo CMIAc
  1. * The following assays were used in the study: Determine HIV 1/2 (Inverness Medical Innovations, Petchabun, Japan), SD Bioline HIV 1/2 version 3 (Youngin-Si, South Korea), Bioline HIV 1/2 (Petchaboon, Thailand), Uni-Gold HIV (Trinity Biotech plc, Bray, Ireland), Clearview HIV 1/2 STAT-PAK (Inverness Medical Innovations, Waltham, MA), OraQuick HIV 1/2 Rapid Antibody Test (OraSure Technologies, Inc., Bethlehem, PA), ARCHITECT HIV Ag/Ab Combo (Abbott Diagnostics, Wiesbaden, Germany). CMIA: chemiluminescent microparticle immunoassay.
  2. a Recommended by the USAID [pdf.usaid.gov/pdf_docs/PNADO095.pdf] accessed 11/23/10 - HIV Test Kits Listed in the USAID Source and Origin Waiver: Procurement Information Document, Fifth Edition, Edited by Abiola Johnson, January 2009].
  3. b Cleared by the Thailand Food and Drug Administration.
  4. c Cleared by the United States Food and Drug Administration.